Genmab announces oncology collaboration with Abbvie
Genmab A/S (Nasdaq: GMAB) and AbbVie Inc. (NYSE: ABBV) announced that Genmab and AbbVie have signed a broad collaboration agreement to jointly develop and commercialize three of Genmab’s early-stage investigational bispecific antibody product candidates